MWPCG
Measured Wealth Private Client Group’s Protalix BioTherapeutics PLX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-38,116
| Closed | -$148K | – | 138 |
|
|
2020
Q3 | $148K | Hold |
38,116
| – | – | 0.07% | 134 |
|
|
2020
Q2 | $144K | Hold |
38,116
| – | – | 0.08% | 121 |
|
|
2020
Q1 | $90K | Hold |
38,116
| – | – | 0.07% | 100 |
|
|
2019
Q4 | $125K | Hold |
38,116
| – | – | 0.08% | 102 |
|
|
2019
Q3 | $8K | Hold |
38,116
| – | – | 0.01% | 133 |
|
|
2019
Q2 | $18K | Hold |
38,116
| – | – | 0.01% | 200 |
|
|
2019
Q1 | $17K | Buy |
+38,116
| New | +$17K | 0.01% | 174 |
|